All sponsors

Betta Pharmaceuticals Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-31
RECRUITING5
READOUTS ≤12 MONTHS0
Open Betta Pharmaceuticals Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
MCLA-129
NCT06885840
P2Not yet recruitingNon-Small Cell Lung Cancer1002028-04
MCLA-129
NCT04930432
P1/2RecruitingSolid Tumor; Non-Small Cell Lung Cancer4002028-04-30 (+46 mo)
NCT06041776
NCT06041776
P3RecruitingNon-Small Cell Lung Cancer; EGFR Sensitive Mutation5702028-04-30
Befotertinib
NCT07181499
P2RecruitingNSCLC; Adjuvant Drug Therapy282028-11
BPI-572270
NCT07435038
P1/2RecruitingNon-small Cell Lung Cancer (NSCLC); Colorectal Cancer (CRC)1202028-12-28
MCLA-129
NCT07448116
P1/2RecruitingSolid Advanced Tumor1642029-02-01